Douglas Lane & Associates’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,075
| Closed | -$302K | – | 241 |
|
|
2024
Q1 | $302K | Buy |
4,075
+96
| +2% | +$6.69K | ﹤0.01% | 207 |
|
|
2023
Q4 | $263K | Sell |
3,979
-610
| -13% | -$38.2K | ﹤0.01% | 215 |
|
|
2023
Q3 | $289K | Sell |
4,589
-2,865
| -38% | -$178K | ﹤0.01% | 203 |
|
|
2023
Q2 | $421K | Sell |
7,454
-1,285
| -15% | -$71.3K | 0.01% | 182 |
|
|
2023
Q1 | $506K | Sell |
8,739
-20
| -0.2% | -$1.35K | 0.01% | 175 |
|
|
2022
Q4 | $634K | Sell |
8,759
-1,465
| -14% | -$105K | 0.01% | 164 |
|
|
2022
Q3 | $621K | Buy |
10,224
+493
| +5% | +$31.5K | 0.01% | 160 |
|
|
2022
Q2 | $611K | Buy |
9,731
+170
| +2% | +$11.3K | 0.01% | 164 |
|
|
2022
Q1 | $672K | Sell |
9,561
-3,085
| -24% | -$209K | 0.01% | 169 |
|
|
2021
Q4 | $790K | Buy |
12,646
+4,541
| +56% | +$285K | 0.01% | 161 |
|
|
2021
Q3 | $500K | Sell |
8,105
-1,439
| -15% | -$86.6K | 0.01% | 175 |
|
|
2021
Q2 | $571K | Sell |
9,544
-3,820
| -29% | -$242K | 0.01% | 164 |
|
|
2021
Q1 | $812K | Sell |
13,364
-3,740
| -22% | -$206K | 0.01% | 148 |
|
|
2020
Q4 | $803K | Sell |
17,104
-169,375
| -91% | -$7.34M | 0.01% | 146 |
|
|
2020
Q3 | $6.93M | Sell |
186,479
-179,714
| -49% | -$6.82M | 0.14% | 106 |
|
|
2020
Q2 | $13.4M | Sell |
366,193
-72,021
| -16% | -$2.51M | 0.29% | 90 |
|
|
2020
Q1 | $13.4M | Sell |
438,214
-180,463
| -29% | -$8M | 0.35% | 87 |
|
|
2019
Q4 | $31.5M | Sell |
618,677
-99,215
| -14% | -$4.79M | 0.59% | 66 |
|
|
2019
Q3 | $33.9M | Sell |
717,892
-314,443
| -30% | -$15M | 0.67% | 59 |
|
|
2019
Q2 | $51.3M | Sell |
1,032,335
-162,140
| -14% | -$7.62M | 1% | 47 |
|
|
2019
Q1 | $50.8M | Sell |
1,194,475
-89,547
| -7% | -$3.96M | 1.05% | 40 |
|
|
2018
Q4 | $52.7M | Sell |
1,284,022
-54,038
| -4% | -$2.32M | 1.24% | 31 |
|
|
2018
Q3 | $62.5M | Sell |
1,338,060
-47,081
| -3% | -$2.15M | 1.23% | 32 |
|
|
2018
Q2 | $60.4M | Sell |
1,385,141
-2,255
| -0.2% | -$105K | 1.28% | 31 |
|
|
2018
Q1 | $63.7M | Buy |
1,387,396
+3,336
| +0.2% | +$162K | 1.38% | 23 |
|
|
2017
Q4 | $70M | Sell |
1,384,060
-3,611
| -0.3% | -$190K | 1.48% | 21 |
|
|
2017
Q3 | $72.1M | Sell |
1,387,671
-185,686
| -12% | -$9.04M | 1.65% | 12 |
|
|
2017
Q2 | $77M | Buy |
1,573,357
+33,608
| +2% | +$1.56M | 1.82% | 10 |
|
|
2017
Q1 | $72.5M | Buy |
1,539,749
+2,654
| +0.2% | +$127K | 1.81% | 9 |
|
|
2016
Q4 | $73.8M | Sell |
1,537,095
-8,412
| -0.5% | -$386K | 1.88% | 7 |
|
|
2016
Q3 | $61.2M | Buy |
1,545,507
+254,102
| +20% | +$9.55M | 1.63% | 14 |
|
|
2016
Q2 | $45.8M | Buy |
1,291,405
+56,341
| +5% | +$2.2M | 1.32% | 25 |
|
|
2016
Q1 | $48.4M | Buy |
+1,235,064
| New | +$46.2M | 1.32% | 24 |
|
Other funds holding MET
Douglas Lane & Associates's MET Position: Q2 2024 in Review
Douglas Lane & Associates sold out of MetLife (MET) in Q2 2024, closing a stake of 4,075 shares — an estimated $302K sold.
Douglas Lane & Associates first reported a position in MET in Q1 2016 and held it in 33 quarters. The position peaked at $77M in Q2 2017. 1,296 funds tracked by Wall St. Rank hold MET as of Q2 2024.
- Douglas Lane & Associates reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
- Douglas Lane & Associates sold 4,075 MetLife shares in Q2 2024, an estimated $302K.
- Douglas Lane & Associates first reported a position in MetLife in Q1 2016 and held it in 33 quarters.
- Douglas Lane & Associates's MetLife position peaked at $77M in Q2 2017.
- 1,296 funds tracked by Wall St. Rank held MetLife as of Q2 2024.
Based on Douglas Lane & Associates's 13F filing for Q2 2024, filed 8 Jul 2024.